title: Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm.
abstract: The initiation of GnRH antagonists when the lead follicle is >14 mm does not adversely affect IVF success rates and leads to a shortened duration of GnRH antagonist administration.
authors.forename: Sigal
authors.initials: S
authors.lastname: Klipstein
authors.forename: Richard H
authors.initials: RH
authors.lastname: Reindollar
authors.forename: Meredith M
authors.initials: MM
authors.lastname: Regan
authors.forename: Michael M
authors.initials: MM
authors.lastname: Alper
mesh_terms: D000328:Adult; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000000981:diagnostic imaging / Q000628:therapy*; D006080:Ovarian Follicle / Q000000981:diagnostic imaging*; D014463:Ultrasonography
chemical_list: D007987:Gonadotropin-Releasing Hormone; C061018:ganirelix